Table 2.
Statin treatment patterns among ASCVD patients, by annual cohort
| Treatment patterns | 2012 | 2013 | 2014 | |||
|---|---|---|---|---|---|---|
| n | % | n | % | n | % | |
| High-intensity statin | ||||||
| Total no. of patients | 1045 | 1516 | 1722 | |||
| Same statin prescription and dose post-index | 669 | 64.0 | 1045 | 68.9 | 1286 | 74.7 |
| Other statin prescription but same dose post-index | 24 | 2.3 | 18 | 1.2 | 15 | 0.9 |
| Down-titrating | 97 | 9.3 | 147 | 9.7 | 154 | 8.9 |
| Discontinuing | 255 | 24.4 | 306 | 20.2 | 267 | 15.5 |
| High- or moderate-intensity statin | ||||||
| Total no. of patients | 13,017 | 14,180 | 14,343 | |||
| Same statin prescription and dose post-index | 10,231 | 78.6 | 11,360 | 80.1 | 11,639 | 81.1 |
| Other statin prescription but same dose post-index | 187 | 1.4 | 189 | 1.3 | 159 | 1.1 |
| Up-titrating | 130 | 1.0 | 128 | 0.9 | 124 | 0.9 |
| Down-titrating | 385 | 3.0 | 403 | 2.8 | 374 | 2.6 |
| Discontinuing | 2084 | 16.0 | 2100 | 14.8 | 2047 | 14.3 |
ASCVD atherosclerotic cardiovascular disease